Triazolam

HALCION 0,125 mg COMPRIMIDOS

0,125 mg comprimidoSpainMarketedAuthorised 30 Sept 1988

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Triazolam

HALCION 0,125 mg COMPRIMIDOS

0,125 mg comprimidoSpainMarketedAuthorised 30 Sept 1988

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AnyNew Zealand · Tab 125 mcg

TriazolamUnited States · 0.125MG, 0.25MG · tablet · Ingenus Pharms LLC

Packs

Pack	Code	Status
HALCION 0,125 mg COMPRIMIDOS , 30 comprimidos	698993

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Triazolam
Strength: 0,125 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Sept 1988
Registration: 58118
Marketing authorisation holder: Pfizer S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Psicótropos